Literature DB >> 27381491

Pelvic recurrence of an ovarian seromucinous borderline tumor detected by vaginal cytology: A case report and review of the literature.

Hironori Hayashi1, Shuichi Taniguchi1, Shuichi Kurihara2, Kazuhisa Hachisuga1, Saori Fukuda3, Chifumi Inada3, Yoshiya Shimao3, Kousuke Marutsuka3, Tomihiro Shimamoto1.   

Abstract

Seromucinous borderline tumors are typically confined to the ovaries and rarely relapse after surgery. We report the case of a woman with a seromucinous borderline tumor with peritoneal implant at the Douglas pouch, who was affected by a recurrent tumor at the vaginal stump 2 years and 6 months after the primary surgery. The recurrent lesion was detected by vaginal cytology. Histology of the recurrent lesion showed perineural infiltration, and progression to low-grade adenocarcinoma was suggested. After the second surgery, vaginal cytology showed that the tumor cells remained positive. At postoperative follow-ups of ovarian borderline tumors, an examination of the specific region where recurrence is likely to occur can contribute to the early detection of tumor relapse. Diagn. Cytopathol. 2016;44:912-916.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ovarian borderline tumor; ovary; recurrence; seromucinous borderline tumor

Mesh:

Year:  2016        PMID: 27381491     DOI: 10.1002/dc.23525

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  1 in total

1.  Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy.

Authors:  Takashi Uehara; Hiroshi Yoshida; Tomoyasu Kato
Journal:  Gynecol Oncol Rep       Date:  2020-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.